Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DOW INC.DOW · Entity 3233 | Senior Vice President / CTO | November 28, 2025 | December 02, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DOW INC.
Report date November 28, 2025 · Filed December 02, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 129,791 |
Reported balance
After 2025-11-28 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-11-28 · Disposition to issuer · Disposed 407 · Balance 129,791 F1: Represents shares withheld by the Issuer to satisfy the payment of withholding tax obligations; share withholding was implemented pursuant to the award agreement and is exempt under Rule 16b-3. F2: Total includes previously reported restricted stock units. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 41,296 |
Reported balance
Holding disclosure · report date 2025-11-28 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 41,296 |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 2,613.755 |
Reported balance
Holding disclosure · report date 2025-11-28 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 2,613.755 |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan ESOP | 1,312.067 |
Reported balance
Holding disclosure · report date 2025-11-28 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 1,312.067 |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Issuer to satisfy the payment of withholding tax obligations; share withholding was implemented pursuant to the award agreement and is exempt under Rule 16b-3.
F2: Total includes previously reported restricted stock units.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DOW CHEMICAL CO /DE/
Report date August 31, 2017 · Filed September 05, 2017
Section 16 reporting ended · disclosed 2017-09-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 1
1 source rowRow 1 · 2017-08-31 · Disposition to issuer · Disposed 161,776.188 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F2: Includes 9,110 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 10,100 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 10,630 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment. |
| CommonSEC Table I · non-derivative | IndirectBy 401(k) Plan | 0 |
Reported balance
After 2017-08-31 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2017-08-31 · Disposition to issuer · Disposed 212.1409 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. |
| CommonSEC Table I · non-derivative | IndirectBy 401(k) Plan ESOP | 0 |
Reported balance
After 2017-08-31 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2017-08-31 · Disposition to issuer · Disposed 919.218 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.19 · Expires 2027-02-10 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-08-31 · Disposition to issuer · Disposed 54,020 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F3: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.01 · Expires 2026-02-12 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-08-31 · Disposition to issuer · Disposed 33,941 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F5: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.44 · Expires 2025-02-13 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-08-31 · Disposition to issuer · Disposed 15,508 · Balance 0 F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.
F2: Includes 9,110 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 10,100 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 10,630 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment.
F3: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms.
F4: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option.
F5: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019.
F6: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2017 Filed Aug 11, 2017 20:42 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Exercise / conversionCommon | 34,810 | $46.71 | $1,625,975.10 |
DisclosureSEC source: 0001225208-17-013935 · doc4.xml · nonDerivative · entry 3 Sreeram Attiganal N · CIK 0001588278 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 206,594.188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 20:42 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Exercise / conversionCommon | 38,690 | $9.53 | $368,715.70 |
DisclosureSEC source: 0001225208-17-013935 · doc4.xml · nonDerivative · entry 2 Sreeram Attiganal N · CIK 0001588278 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 171,784.188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 20:42 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Exercise / conversionCommon | 39,170 | $32.16 | $1,259,707.20 |
DisclosureSEC source: 0001225208-17-013935 · doc4.xml · nonDerivative · entry 1 Sreeram Attiganal N · CIK 0001588278 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,094.188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 21:18 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Tax withholdingCommon | 2,247 | $61.72 | $138,684.84 |
DisclosureSEC source: 0001225208-17-003576 · doc4.xml · nonDerivative · entry 1 Sreeram Attiganal N · CIK 0001588278 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,924.188 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. F2 · shares: Stock withheld on the delivery date to cover taxes for deferred stock granted on February 14, 2014, as previously reported. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 21:14 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 54,020 | $0.00 Strike: $61.19 | $0.00 |
DisclosureSEC source: 0001225208-17-003211 · doc4.xml · derivative · entry 4 Sreeram Attiganal N · CIK 0001588278 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,020 Underlying: Common · 54,020 shares Expires 2027-02-10 F1 · security: Granted under The Dow Chemical Company 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 10, 2018. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 21:14 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | GrantCommon | 10,630 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003211 · doc4.xml · nonDerivative · entry 1 Sreeram Attiganal N · CIK 0001588278 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,171.188 F1 · security: Granted under The Dow Chemical Company 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F2 · shares: Deferred shares to be delivered in one installment on or about February 10, 2020 contingent upon continuation of employment. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 21:20 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 18,470 | $0.00 Strike: $43.59 | $0.00 |
DisclosureSEC source: 0001225208-17-002178 · doc4.xml · derivative · entry 6 Sreeram Attiganal N · CIK 0001588278 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 18,470 shares Expires 2017-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted under The Dow Chemical Company 1988 Award and Option Plan. The Plan provides for tax withholding rights. F3 · derivative.exercise_date: The options vested in three equal annual installments beginning on February 16, 2008. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 21:20 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Tax withholdingCommon | 13,097 | $61.48 | $805,138.08 |
DisclosureSEC source: 0001225208-17-002178 · doc4.xml · nonDerivative · entry 3 Sreeram Attiganal N · CIK 0001588278 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,541.188 Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 21:20 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Tax withholdingCommon | 1,735 | $61.48 | $106,659.13 |
DisclosureSEC source: 0001225208-17-002178 · doc4.xml · nonDerivative · entry 2 Sreeram Attiganal N · CIK 0001588278 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,638.188 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. Read SEC document |
| January 30, 2017 Filed Feb 1, 2017 21:20 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Exercise / conversionCommon | 18,470 | $43.59 | $805,107.30 |
DisclosureSEC source: 0001225208-17-002178 · doc4.xml · nonDerivative · entry 1 Sreeram Attiganal N · CIK 0001588278 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,373.188 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.